The Human Diabetes Proteome Project (HDPP): The 2014 update

D. Schvartz; Patrik Bergsten; K. H. Baek; A. Barba De La Rosa; J. Cantley; L. Dayon; F. Finamore; P. Fontana; P. Gaudet; Y. A. Goo; R. Moulder; David R Goodlett; J. D. Johnson; A. Konvalinka; Hindrik Mulder; F. Priego-Capote; Salvatore Sechi; Kathleen M. Snyder; A. Tiss; A. Wiederkehr; I. Xenarios; Martin Kussmann; J. C. Sanchez

doi:10.1016/j.trprot.2015.03.001

The Human Diabetes Proteome Project (HDPP): The 2014 update

D. Schvartz, Patrik Bergsten, K. H. Baek, A. Barba De La Rosa, J. Cantley, L. Dayon, F. Finamore, P. Fontana, P. Gaudet, Y. A. Goo, R. Moulder, David R Goodlett, J. D. Johnson, A. Konvalinka, Hindrik Mulder, F. Priego-Capote, Salvatore Sechi, Kathleen M. Snyder, A. Tiss, A. WiederkehrI. Xenarios, Martin Kussmann, J. C. Sanchez

Research output: Contribution to journal › Article › peer-review

Abstract

Diabetes is an increasing worldwide problem leading to major associated health issues and increased health care costs. In 2012, 9.3% of the American population was affected by diabetes, according to the American Diabetes Association, with 1.7 million of new cases since during the year (www.diabetes.org). Proteome initiatives can provide a deeper understanding of the biology of this disease and help develop more effective treatments. The collaborative effort of the Human Diabetes Proteome Project (HDPP) brings together a wide variety of complementary resources to increase the existing knowledge about both type 1 and type 2 diabetes and their related complications. The goals are to identify proteins and protein isoforms associated with the pathology and to characterize underlying disease-related pathways and mechanisms. Moreover, a considerable effort is being made on data integration and network biology. Sharing these data with the scientific community will be an important part of the consortium. Here we report on: the content of the HDPP session held at the 12th HUPO meeting in Yokohama; recent achievements of the consortium; discussions of several HDPP workshops; as well as future HDPP directions as discussed at the 13th HUPO congress in Madrid, with a special attention given to the lists of prioritized, diabetes-related proteins and the proteomic means to study them.

Original language	English
Pages (from-to)	1-7
Number of pages	7
Journal	Translational Proteomics
Volume	8-9
DOIs	https://doi.org/10.1016/j.trprot.2015.03.001
Publication status	Published - 2015 Dec 1

Subject classification (UKÄ)

Endocrinology and Diabetes
Cell and Molecular Biology

Free keywords

B/D-HPP
Blood
Diabetes
HDPP
HPP
Human proteome
Islet
Network biology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.trprot.2015.03.001

Cite this

Schvartz, D., Bergsten, P., Baek, K. H., De La Rosa, A. B., Cantley, J., Dayon, L., Finamore, F., Fontana, P., Gaudet, P., Goo, Y. A., Moulder, R., Goodlett, D. R., Johnson, J. D., Konvalinka, A., Mulder, H., Priego-Capote, F., Sechi, S., Snyder, K. M., Tiss, A., ... Sanchez, J. C. (2015). The Human Diabetes Proteome Project (HDPP): The 2014 update. Translational Proteomics, 8-9, 1-7. https://doi.org/10.1016/j.trprot.2015.03.001

@article{9a97218509d34f40b5e2f6a13db19065,

title = "The Human Diabetes Proteome Project (HDPP): The 2014 update",

abstract = "Diabetes is an increasing worldwide problem leading to major associated health issues and increased health care costs. In 2012, 9.3% of the American population was affected by diabetes, according to the American Diabetes Association, with 1.7 million of new cases since during the year (www.diabetes.org). Proteome initiatives can provide a deeper understanding of the biology of this disease and help develop more effective treatments. The collaborative effort of the Human Diabetes Proteome Project (HDPP) brings together a wide variety of complementary resources to increase the existing knowledge about both type 1 and type 2 diabetes and their related complications. The goals are to identify proteins and protein isoforms associated with the pathology and to characterize underlying disease-related pathways and mechanisms. Moreover, a considerable effort is being made on data integration and network biology. Sharing these data with the scientific community will be an important part of the consortium. Here we report on: the content of the HDPP session held at the 12th HUPO meeting in Yokohama; recent achievements of the consortium; discussions of several HDPP workshops; as well as future HDPP directions as discussed at the 13th HUPO congress in Madrid, with a special attention given to the lists of prioritized, diabetes-related proteins and the proteomic means to study them.",

keywords = "B/D-HPP, Blood, Diabetes, HDPP, HPP, Human proteome, Islet, Network biology",

author = "D. Schvartz and Patrik Bergsten and Baek, {K. H.} and {De La Rosa}, {A. Barba} and J. Cantley and L. Dayon and F. Finamore and P. Fontana and P. Gaudet and Goo, {Y. A.} and R. Moulder and Goodlett, {David R} and Johnson, {J. D.} and A. Konvalinka and Hindrik Mulder and F. Priego-Capote and Salvatore Sechi and Snyder, {Kathleen M.} and A. Tiss and A. Wiederkehr and I. Xenarios and Martin Kussmann and Sanchez, {J. C.}",

year = "2015",

month = dec,

day = "1",

doi = "10.1016/j.trprot.2015.03.001",

language = "English",

volume = "8-9",

pages = "1--7",

journal = "Translational Proteomics",

issn = "2212-9626",

publisher = "Elsevier",

}

Schvartz, D, Bergsten, P, Baek, KH, De La Rosa, AB, Cantley, J, Dayon, L, Finamore, F, Fontana, P, Gaudet, P, Goo, YA, Moulder, R, Goodlett, DR, Johnson, JD, Konvalinka, A, Mulder, H, Priego-Capote, F, Sechi, S, Snyder, KM, Tiss, A, Wiederkehr, A, Xenarios, I, Kussmann, M & Sanchez, JC 2015, 'The Human Diabetes Proteome Project (HDPP): The 2014 update', Translational Proteomics, vol. 8-9, pp. 1-7. https://doi.org/10.1016/j.trprot.2015.03.001

TY - JOUR

T1 - The Human Diabetes Proteome Project (HDPP)

T2 - The 2014 update

AU - Schvartz, D.

AU - Bergsten, Patrik

AU - Baek, K. H.

AU - De La Rosa, A. Barba

AU - Cantley, J.

AU - Dayon, L.

AU - Finamore, F.

AU - Fontana, P.

AU - Gaudet, P.

AU - Goo, Y. A.

AU - Moulder, R.

AU - Goodlett, David R

AU - Johnson, J. D.

AU - Konvalinka, A.

AU - Mulder, Hindrik

AU - Priego-Capote, F.

AU - Sechi, Salvatore

AU - Snyder, Kathleen M.

AU - Tiss, A.

AU - Wiederkehr, A.

AU - Xenarios, I.

AU - Kussmann, Martin

AU - Sanchez, J. C.

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Diabetes is an increasing worldwide problem leading to major associated health issues and increased health care costs. In 2012, 9.3% of the American population was affected by diabetes, according to the American Diabetes Association, with 1.7 million of new cases since during the year (www.diabetes.org). Proteome initiatives can provide a deeper understanding of the biology of this disease and help develop more effective treatments. The collaborative effort of the Human Diabetes Proteome Project (HDPP) brings together a wide variety of complementary resources to increase the existing knowledge about both type 1 and type 2 diabetes and their related complications. The goals are to identify proteins and protein isoforms associated with the pathology and to characterize underlying disease-related pathways and mechanisms. Moreover, a considerable effort is being made on data integration and network biology. Sharing these data with the scientific community will be an important part of the consortium. Here we report on: the content of the HDPP session held at the 12th HUPO meeting in Yokohama; recent achievements of the consortium; discussions of several HDPP workshops; as well as future HDPP directions as discussed at the 13th HUPO congress in Madrid, with a special attention given to the lists of prioritized, diabetes-related proteins and the proteomic means to study them.

AB - Diabetes is an increasing worldwide problem leading to major associated health issues and increased health care costs. In 2012, 9.3% of the American population was affected by diabetes, according to the American Diabetes Association, with 1.7 million of new cases since during the year (www.diabetes.org). Proteome initiatives can provide a deeper understanding of the biology of this disease and help develop more effective treatments. The collaborative effort of the Human Diabetes Proteome Project (HDPP) brings together a wide variety of complementary resources to increase the existing knowledge about both type 1 and type 2 diabetes and their related complications. The goals are to identify proteins and protein isoforms associated with the pathology and to characterize underlying disease-related pathways and mechanisms. Moreover, a considerable effort is being made on data integration and network biology. Sharing these data with the scientific community will be an important part of the consortium. Here we report on: the content of the HDPP session held at the 12th HUPO meeting in Yokohama; recent achievements of the consortium; discussions of several HDPP workshops; as well as future HDPP directions as discussed at the 13th HUPO congress in Madrid, with a special attention given to the lists of prioritized, diabetes-related proteins and the proteomic means to study them.

KW - B/D-HPP

KW - Blood

KW - Diabetes

KW - HDPP

KW - HPP

KW - Human proteome

KW - Islet

KW - Network biology

UR - http://www.scopus.com/inward/record.url?scp=84994462692&partnerID=8YFLogxK

U2 - 10.1016/j.trprot.2015.03.001

DO - 10.1016/j.trprot.2015.03.001

M3 - Article

AN - SCOPUS:84994462692

SN - 2212-9626

VL - 8-9

SP - 1

EP - 7

JO - Translational Proteomics

JF - Translational Proteomics

ER -

The Human Diabetes Proteome Project (HDPP): The 2014 update

Abstract

Subject classification (UKÄ)

Free keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this